Mark A. Velleca Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark A. Velleca.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark A. Velleca. Mark A. Velleca is in G1 Therapeutics, Inc. ($GTHX) and President and CEO in G1 Therapeutics, Inc. ($GTHX).
Latest Insider Trading Transactions of Mark A. Velleca
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 307,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 307,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 317,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 317,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 327,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 327,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.54 | 10,000 | 205,413 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.54 | 10,000 | 205,413 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.07 | 10,000 | 200,691 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.07 | 10,000 | 200,691 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 19.10 | 10,000 | 190,997 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 19.10 | 10,000 | 190,997 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 337,286 | ||
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 347,286 | ||
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 357,286 | ||
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 24.96 | 10,000 | 249,631 | 41,000 | 51 K to 41 K (-19.61 %) | |
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 24.53 | 10,000 | 245,272 | 41,000 | 51 K to 41 K (-19.61 %) | |
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 23.89 | 10,000 | 238,865 | 41,000 | 51 K to 41 K (-19.61 %) | |
| Apr 15 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 28,393 | ||
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 38,393 | ||
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 11,040 | 41,069 | 48,393 | ||
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 26.02 | 10,000 | 260,152 | 41,000 | 51 K to 41 K (-19.61 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 28.41 | 600 | 17,046 | 41,000 | 41.6 K to 41 K (-1.44 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 27.59 | 9,400 | 259,387 | 41,600 | 51 K to 41.6 K (-18.43 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 37.00 | 23 | 851 | 41,000 | 41 K to 41 K (-0.06 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 36.22 | 2,700 | 97,781 | 41,023 | 43.7 K to 41 K (-6.18 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 34.87 | 8,317 | 290,021 | 43,723 | 52 K to 43.7 K (-15.98 %) | |
| Feb 18 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 11,040 | 41,069 | 52,040 | 41 K to 52 K (+26.93 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 59,433 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 4,000 | 1,560 | 367,286 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 69,433 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 3.72 | 10,000 | 37,200 | 79,433 | ||
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.64 | 10,000 | 206,400 | 41,000 | 51 K to 41 K (-19.61 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 51,000 | 41 K to 51 K (+24.39 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 4,000 | 1,560 | 41,000 | 37 K to 41 K (+10.81 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 21.51 | 10,000 | 215,107 | 37,000 | 47 K to 37 K (-21.28 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.88 | 10,000 | 208,781 | 37,000 | 47 K to 37 K (-21.28 %) | |
| Jan 21 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 10,000 | 37,200 | 89,433 | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 10,000 | 37,200 | 99,433 | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 10,000 | 37,200 | 109,433 | |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 19.97 | 10,000 | 199,668 | 37,000 | 47 K to 37 K (-21.28 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 19.20 | 10,000 | 192,021 | 37,000 | 47 K to 37 K (-21.28 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 19.43 | 10,000 | 194,297 | 37,000 | 47 K to 37 K (-21.28 %) |
| Dec 17 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 10,000 | 37,200 | 47,000 | 37 K to 47 K (+27.03 %) |
| Mar 16 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 3,000 | 1,170 | 371,286 | |
| Mar 16 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 3,000 | 1,170 | 37,000 | 34 K to 37 K (+8.82 %) |
| Jan 24 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 6,000 | 2,340 | 374,286 | |
| Jan 24 2020 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 6,000 | 2,340 | 34,000 | 28 K to 34 K (+21.43 %) |
| Jan 17 2019 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 9,000 | 3,510 | 380,286 | |
| Jan 17 2019 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 9,000 | 3,510 | 28,000 | 19 K to 28 K (+47.37 %) |
| Jan 02 2019 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | A | 19.56 | 225,000 | 4,401,000 | 225,000 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 119,433 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 40.59 | 15 | 609 | 19,000 | 19 K to 19 K (-0.08 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 39.84 | 4,985 | 198,602 | 19,015 | 24 K to 19 K (-20.77 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 24,000 | 19 K to 24 K (+26.32 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 124,433 | |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,900 | 389,286 | |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 42.01 | 2,837 | 119,177 | 19,000 | 21.8 K to 19 K (-12.99 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 40.90 | 2,163 | 88,469 | 21,837 | 24 K to 21.8 K (-9.01 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 24,000 | 19 K to 24 K (+26.32 %) |
| Oct 15 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 10,000 | 3,900 | 19,000 | 9 K to 19 K (+111.11 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 129,433 | |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 67.95 | 300 | 20,385 | 9,000 | 9.3 K to 9 K (-3.23 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 66.92 | 1,865 | 124,798 | 9,300 | 11.2 K to 9.3 K (-16.70 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 65.74 | 2,835 | 186,366 | 11,165 | 14 K to 11.2 K (-20.25 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 14,000 | 9 K to 14 K (+55.56 %) |
| Aug 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 134,433 | |
| Aug 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 56.52 | 2,301 | 130,046 | 9,000 | 11.3 K to 9 K (-20.36 %) |
| Aug 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 55.33 | 2,699 | 149,332 | 11,301 | 14 K to 11.3 K (-19.28 %) |
| Aug 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 14,000 | 9 K to 14 K (+55.56 %) |
| Jul 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 139,433 | |
| Jul 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 42.71 | 1,200 | 51,255 | 9,000 | 10.2 K to 9 K (-11.76 %) |
| Jul 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 41.86 | 3,800 | 159,058 | 10,200 | 14 K to 10.2 K (-27.14 %) |
| Jul 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 14,000 | 9 K to 14 K (+55.56 %) |
| Jul 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Gift | G | 0.00 | 1,000 | 0 | 9,000 | 10 K to 9 K (-10.00 %) |
| May 31 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,900 | 399,286 | |
| May 31 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 144,433 | |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 46.63 | 1,700 | 79,277 | 0 | 1.7 K to 0 (-100.00 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 46.17 | 5,800 | 267,787 | 1,700 | 7.5 K to 1.7 K (-77.33 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Apr 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 151,933 | |
| Apr 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 36.71 | 500 | 18,355 | 0 | 500 to 0 (-100.00 %) |
| Apr 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 35.95 | 7,000 | 251,616 | 500 | 7.5 K to 500 (-93.33 %) |
| Apr 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Mar 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 159,433 | |
| Mar 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 38.20 | 7,500 | 286,466 | 0 | 7.5 K to 0 (-100.00 %) |
| Mar 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Feb 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 166,933 | |
| Feb 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 20.00 | 7,500 | 150,015 | 0 | 7.5 K to 0 (-100.00 %) |
| Feb 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Feb 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 166,933 | |
| Feb 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 20.00 | 7,500 | 150,015 | 0 | 7.5 K to 0 (-100.00 %) |
| Feb 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Jan 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 174,433 | |
| Jan 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 22.99 | 7,500 | 172,395 | 0 | 7.5 K to 0 (-100.00 %) |
| Jan 17 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| Jan 04 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | A | 20.49 | 75,000 | 1,536,750 | 75,000 | |
| Dec 20 2017 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 181,933 | |
| Dec 20 2017 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 20.01 | 7,500 | 150,106 | 0 | 7.5 K to 0 (-100.00 %) |
| Dec 20 2017 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
Page: 1